Publication:
Giant cell arteritis: is the clinical spectrum of the disease changing?

Loading...
Thumbnail Image
Date
2019-07-29
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central Ltd.
Export
Research Projects
Organizational Units
Journal Issue
Abstract
Background: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and treatment is essential to avoid irreversible damage. Discussion: There has been an increasing knowledge on the occurrence of the disease without the typical cranial symptoms and its close relationship and overlap with polymyalgia rheumatica, and this may contribute to reduce the number of underdiagnosed patients. Although temporal artery biopsy is still the gold-standard and temporal artery ultrasonography is being widely used, newer imaging techniques (FDG-PET/TAC, MRI, CT) can be of valuable help to identify giant cell arteritis, in particular in those cases with a predominance of extracranial large-vessel manifestations. Conclusions: Giant cell arteritis is a more heterogeneous condition than previously thought. Awareness of all the potential clinical manifestations and judicious use of diagnostic tests may be an aid to avoid delayed detection and consequently ominous complications.
Description
DeCS Terms
CIE Terms
Keywords
Giant-cell arteritis, Polymyalgia rheumatic, FDG-PET/CT, Arteritis de células gigantes, Polimialgia reumática, Fluorodeoxyglucose F18, Fluorodesoxiglucosa F18, Positron Emission Tomography Computed Tomography, Tomografía Computarizada por Tomografía de Emisión de Positrones
Citation
González-Gay MÁ, Ortego-Jurado M, Ercole L, Ortego-Centeno N. Giant cell arteritis: is the clinical spectrum of the disease changing? BMC Geriatr. 2019 Jul 29;19(1):200.